Ultragenyx Pharmaceutical | RARE - 당기 순이익

주가
19.71
매일 변경
-0.16 -0.81%
매월
-12.44%
매년
-49.69%
Q1 예상
19.27




당기 순이익 변화 날짜
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Immunic USD -24.37M 2.99M 2024-09
Insmed USD -328.48M 41.54M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Kyowa Hakko Kirin JPY 34.44B 18.16B 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
Moderna USD -200M 625M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Xoma USD -17.24M 33.23M 2024-09